 but replication defective means we actually don't want it to act like a virus where it goes into the cell multiplies and then goes out what we want to do is we want to use the technology associated with the protein to achieve an outcome and in 1999 going into 2002 the world knew that the thing that had been modified was actually modified so that it would inflame the cardiovascular system